Focused on ophthalmology, the Japanese drugmaker develops and commercializes prescription pharmaceuticals and medical devices for eye conditions such as glaucoma, dry eye, and retinal disorders. The company generates most of its revenue in Japan while expanding across Asia and Europe, positioning it...
This page tracks all publicly disclosed congressional trades in Santen Pharmaceutical Co., Ltd. (SNPHY), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
No congressional trades found for this stock.